These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 6613843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
    Chiale PA, Halpern MS, Nau GJ, Tambussi AM, Przybylski J, Lázzari JO, Elizari MV, Rosenbaum MB.
    Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ, Lown B.
    Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN, Heger JJ, Miles WM, Zipes DP.
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.
    Carrasco HA, Vicuña AV, Molina C, Landaeta A, Reynosa J, Vicuña N, Fuenmayor A, López F.
    Int J Cardiol; 1985 Dec; 9(4):425-38. PubMed ID: 3908329
    [Abstract] [Full Text] [Related]

  • 13. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
    Zipes DP, Prystowsky EN, Heger JJ.
    J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
    [Abstract] [Full Text] [Related]

  • 14. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Amiodarone in the nineties: to whom and what dosage?].
    Moro Serrano C, Hernández Madrid A, Lage Silveira J, Vivas Alvarez E, Kanjhi M.
    Rev Esp Cardiol; 1995 Apr 14; 48(4):272-84. PubMed ID: 7740149
    [No Abstract] [Full Text] [Related]

  • 18. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL, Graham EL, Werner JA, Sears GK, Gross BW, Gorham JP, Kudenchuk PJ, Trobaugh GB.
    J Am Coll Cardiol; 1983 Dec 14; 2(6):1114-28. PubMed ID: 6685151
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
    Nademanee K, Singh BN, Cannom DS, Weiss J, Feld G, Stevenson WG.
    Am Heart J; 1983 Oct 14; 106(4 Pt 2):895-901. PubMed ID: 6613836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.